International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7874447
Case Report
Case Report of Mucopolysaccharidosis type -1 (MPS-1)
 ,
 ,
 ,
Published
April 28, 2023
Abstract
Mucopolysaccharidosis (MPS) represents a heterogenous group of inheritable lysosomal storage disease in which accumulation of undegraded glycosaminoglycans (Gags)- {dermatan sulfate & heparan sulfate}interfere with cell functions and leads to progressive damage of affected tissue. Radiological features; skeletal radiograph and MRI allows theassessmentof the severity of the disease (10). The case highlights that abnormal clinical symptoms, such as growth failure, coarse facial features, and joint problems, are key points for further investigation relating to mucopolysaccharidosis disease. Deficiency of α-L-iduronidase results in a wide range of clinical involvement from severe Hurler disease to mild Scheie disease (MPS I S) & intermediate form Hurler-Scheie disease (MPS I HS) (2).
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2610 Views
432 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved